- Filed
- May 13, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 4, 2026 | 108.5M sh |
| Shares Diluted | Q1 2025 · Apr 3, 2026 | 110.62M sh |
| Shares Diluted | Q1 2025 · Mar 28, 2025 | 117.02M sh |
| Stock Repurchased | Q1 2025 · Apr 3, 2026 | $42.95M |
| Stock Repurchased | Q1 2025 · Mar 28, 2025 | $36.08M |
| Capex | Q1 2025 · Apr 3, 2026 | $1.4M |
| Capex | Q1 2025 · Mar 28, 2025 | $1.87M |
| Operating Cash Flow | Q1 2025 · Apr 3, 2026 | $31.69M |
| Operating Cash Flow | Q1 2025 · Mar 28, 2025 | $83.61M |
| Long Term Debt | Q1 2025 · Apr 3, 2026 | $108.4M |
| Long Term Debt | Q1 2025 · Dec 31, 2025 | $109.14M |
| Short Term Debt | Q1 2025 · Apr 3, 2026 | $2.94M |
| Short Term Debt | Q1 2025 · Dec 31, 2025 | $2.94M |
| Cash And Equivalents | Q1 2025 · Apr 3, 2026 | $109M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2025 | $124.11M |
| Cash And Equivalents | Q1 2025 · Mar 28, 2025 | $148.71M |
| Stockholders Equity | Q1 2025 · Apr 3, 2026 | $355.15M |
| Stockholders Equity | Q1 2025 · Dec 31, 2025 | $383.25M |
| Stockholders Equity | Q1 2025 · Mar 28, 2025 | $446.13M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $465.26M |
| Current Liabilities | Q1 2025 · Apr 3, 2026 | $214.24M |
| Current Liabilities | Q1 2025 · Dec 31, 2025 | $197.95M |
| Total Liabilities | Q1 2025 · Apr 3, 2026 | $350.15M |
| Total Liabilities | Q1 2025 · Dec 31, 2025 | $335.24M |
| Current Assets | Q1 2025 · Apr 3, 2026 | $485.26M |
| Current Assets | Q1 2025 · Dec 31, 2025 | $494.37M |
| Total Assets | Q1 2025 · Apr 3, 2026 | $705.31M |
| Total Assets | Q1 2025 · Dec 31, 2025 | $718.48M |
| Eps Diluted | Q1 2025 · Apr 3, 2026 | $0.07 |
| Eps Diluted | Q1 2025 · Mar 28, 2025 | $0.05 |
| Eps Basic | Q1 2025 · Apr 3, 2026 | $0.07 |
| Eps Basic | Q1 2025 · Mar 28, 2025 | $0.05 |
| Sga Expense | Q1 2025 · Apr 3, 2026 | $22.29M |
| Sga Expense restated | Q1 2025 · Mar 28, 2025 | $19.78M |
| Rd Expense | Q1 2025 · Apr 3, 2026 | $20.88M |
| Rd Expense restated | Q1 2025 · Mar 28, 2025 | $19.66M |
| Net Income | Q1 2025 · Apr 3, 2026 | $7.31M |
| Net Income | Q1 2025 · Mar 28, 2025 | $5.94M |
| Operating Income | Q1 2025 · Apr 3, 2026 | $20.45M |
| Operating Income restated | Q1 2025 · Mar 28, 2025 | $7.04M |
| Gross Profit | Q1 2025 · Apr 3, 2026 | $63.62M |
| Gross Profit restated | Q1 2025 · Mar 28, 2025 | $46.48M |
| Cost Of Revenue | Q1 2025 · Apr 3, 2026 | $58.08M |
| Cost Of Revenue restated | Q1 2025 · Mar 28, 2025 | $38.4M |
| Revenue | Q1 2025 · Apr 3, 2026 | $121.7M |
| Revenue restated | Q1 2025 · Mar 28, 2025 | $84.88M |